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An In Silico Model for Interpreting Polypharmacology
in Drug-Target Networks
Ichigaku Takigawa, Koji Tsuda and Hiroshi Mamitsuka
Summary
Recent analysis on polypharmacology leads to the idea that only small fragments of drugs and
targets are a key to understanding their interactions forming polypharmacology. This idea moti-
vates us to build an in silico approach of ﬁnding signiﬁcant substructure patterns from drug-target
(molecular graph-amino acid sequence) pairs. This article introduces an eﬃcient in silico method
for enumerating, from given drug-target pairs, all frequent subgraph-subsequence pairs, which can
be then examined by hypothesis testing for statistical signiﬁcance further. Unique features of the
method are in scalability, computational eﬃciency and technical soundness in terms of computer
science and statistics. The presented method was applied to 11,219 drug-target pairs in DrugBank
to obtain signiﬁcant substructure pairs, which can divide most of the original 11,219 pairs into
eight highly exclusive clusters, implying that the obtained substructure pairs are indispensable
components for interpreting polypharmacology.
Keywords: Frequent pattern mining, Graphs, Strings, Likelihood-ratio test, Polypharmacology,
Drug-target networks
1 Introduction
Polypharmacology (or drug promiscuity) is a recently emerging concept in drug-target interac-
tions, due to mainly the following three reasons: 1) multi-targeted drugs have been clinically
successful, particularly as dual or multiplex kinase inhibitors [1]. 2) a lot of approved drugs are
not necessarily so selective [2], where a typical example is cancer drugs such as Gleevec (imatinib)
and Sutent (sunitinib) which can bind to multiple kinases [3]. 3) network science, particularly
scale-freeness of drug-target networks imply the robustness of biological systems [4, 5], by which
dysfunction of only a single protein can be in most cases compensated, indicating that inhibiting
a single target would be therapeutically insuﬃcient [6].
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Recent analysis suggests that targets of promiscuous drugs cannot necessarily be similar to
each other [2, 7], meaning that only a small part of each target might be connected to the princi-
ple behind polypharmacology. Furthermore recent research shows that smaller drugs in molecular
weight are likely to be more promiscuous [5], suggesting that only small fragments in each lig-
and would be related to drug promiscuity. They have brought us a hypothesis that fragments
in drug-target pairs, or paired fragments, must be important factors behind polypharmacology.
Thus naturally an in silico approach for analyzing polypharmacology based on this hypothesis is
to use molecular graphs for drugs (or chemical compounds) and amino acid sequences for targets
(or proteins) and examine paired fragments (or substructures) in molecular graphs and amino
acid sequences of drug-target pairs [8]. We introduce a data-driven approach for mining substruc-
ture pairs which signiﬁcantly shared in currently available drug-target (graph-sequence) pairs. A
unique feature of this approach is scalability and eﬃciency for covering all possible substructure
(subgraph-subsequence) pairs which signiﬁcantly co-occur in given drug-target pairs. Further-
more, in [8], obtained signiﬁcant substructure pairs were used for clustering current drug-target
interactions into eight classes, which are highly exclusive each other, implying that each cluster
corresponds to one unique type of promiscuous drugs (or targets) forming polypharmacology.
2 Materials
The ’small molecules’ dataset of DrugBank [9] (version 2.5 as of January 29, 2009), a standard
database on drug information, contains 11,219 drug-target interactions, which are the input as
interacting pairs, including 4,191 compounds which were linked to 4,362 targets. On the other
hand, non-interacting pairs are all possible combinations from 4,191 compounds and 4,362 targets
except the 11,219 drug-target pairs (See Note 1). In drug-target pairs, 1,447 (34.5%) out of 4,191
drugs were promiscuous drugs, i.e. each with at least two targets, and this ratio was consistent
with 35% in [7]. These promiscuous drugs were involved with 8,475 interactions (75.5% of all
11,219 drug-target pairs) and 171,029 interaction pairs. Drugs are treated as molecular graphs
(See Note 2) and targets are represented by amino acid sequences.
3 Methods
The main input of the method is drug-target (or compound-protein) pairs, which are turned into
graph-sequence pairs in the method. The method tries to ﬁnd subgraph-subsequence pairs (See
Note 3), which signiﬁcantly occur in given drug-target pairs, comparing with non-interacting
pairs. This method has two components: (1) all subgraph-subsequence pairs frequently occurring
in drug-target pairs are enumerated, and (2) the signiﬁcance of a frequent subgraph-subsequence
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pair is evaluated. We describe Steps (1) and (2) in Subsections 3.1 and 3.2, respectively. Note
that Step (1) corresponds to the entire procedure of the method, and in Step (1), Step (2) is
performed every time a frequent subgraph-subsequence pair is obtained. Note that Step (2) uses
both drug-target pairs and non-interacting pairs, while Step (1) uses drug-target pairs only.
3.1 Mining frequent subgraph-subsequence pairs
3.1.1 Preliminaries
Given a dataset of graph-sequence pairs, we can count the number of graph-sequence pairs which
contain a certain subgraph-subsequence pair. We call this number support of the corresponding
subgraph-subsequence pair, following the literature of frequent pattern mining [10]. When the
support of a subgraph-subsequence pair is larger than or equal to a given threshold value, which
is called minimum support, this pair is called a frequent subgraph-subsequence pair. That is, the
support of a frequent subgraph-subsequence pair must be larger than or equal to the minimum
support. We can further deﬁne marginal support of a subgraph as the number of given graph-
sequence pairs which have this subgraph. The marginal support can be deﬁned for subsequences
as well.
The ﬁrst, key idea for enumerating all frequent subgraph-subsequence pairs eﬃciently is the
following property, which is called downward closure:
Proposition 1 (Downward closure). A subgraph-subsequence pair is infrequent if this pair con-
tains any smaller infrequent subgraph-subsequence pairs.
This property is powerful, because if you ﬁnd an infrequent subgraph-subsequence pair, you
do not have to search pairs with larger subgraphs and subsequences which include this pair.
Then this idea naturally leads to a so-called pattern-growth approach, in which we can start with
smallest subgraph-subsequence pairs and extend them to larger pairs, and if we come across an
infrequent pair, then we can stop going on to larger pairs due to the downward closure property.
Without loss of generality, we explain this approach more, focusing on sequences only (rather
than graph-sequence pairs). The pattern growth procedure naturally generates a hierarchy, which
can be represented in a rooted ordered tree, called an enumeration tree. The enumeration tree
is a rooted ordered spanning tree over all frequent subsequences, roughly with the following two
features: 1) the null sequence is on the root, and sequences with only one letter are the children
of the root. 2) each node corresponds to a frequent subsequence in a one-to-one manner, where
a subsequence with a larger number of letters are attached to nodes in a deeper level (See Note
4).
An important point of the enumeration tree is that we can enumerate all subsequences com-
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Figure 1: Samples of enumeration trees for (a) frequent subsequences and for (b) frequent sub-
graphs.
shaped search space thus ensures the uniqueness of each subsequence attached to a node and the
completeness on searching all frequent subsequences.
In fact, an enumeration tree can be generated by considering the following three points: 1)
one node has only one parent node but can have more than one child nodes. 2) a subsequence of
a child must be a larger but the minimum. For example, AC in Fig. 1 (a) is a longer sequence but
the minimum of longer sequences. 3) an order of sibling nodes is deﬁned by using some criterion,
by which for example, AC can be a child of A but cannot be a child of C in Fig. 1 (a). That is, A
is prior to C, by which AC is generated from A, being faster than that AC is generated from C.
The enumeration tree can be generated for subgraphs in a similar manner, as shown in Fig.
1 (b), and these subgraphs are used in the next subsection (See Note 5).
We here deﬁne some notations which will be used in the next subsection. Let Q be given
subgraph-subsequence pairs. Let Qg and Qs be subgraph-subsequence pairs containing subgraph
g and subsequence s, respectively. Similarly let Q(g,s) be subgraph-subsequence pairs containing
both subgraph g and subsequence s. Let Tg and Ts be enumeration trees for subgraphs and
subsequences, respectively. Here ∅g and ∅s indicate the root nodes of Tg and Ts, respectively.
Similarly, parent(g) represents a subgraph of the parent of a node to which g is assigned in Tg,
and parent(s) represents a subsequence of the parent of a node to which s is assigned in Ts. The
support of a pair of subgraph g and subsequence s is denoted by support((g, s)|Q) = |Q(g,s)|.
Similarly the marginal support of subsequence s is denoted by support((∗, s)|Q). Let σ be the
minimum support.
3.1.2 Mining algorithm
For mining frequent subgraph-subsequence pairs, we combine two enumeration trees, one for
frequent subgraphs and the other for frequent subsequences. That is, all combinations of frequent
subgraphs and subsequences can cover all frequent subgraph-subsequence pairs, and the search
space for all these combinations can be deﬁned by a product graph of the two enumeration
4
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Figure 2: An example of the search space. The search space (c) is deﬁned as the graph product of
two enumeration trees for subsequences (a) and for subgraphs (b). (c) covers all possible frequent
subgraph-subsequence pairs.
trees. Fig. 2 (a) and (b) show examples of enumeration trees for subsequences and subgraphs,
respectively, which can be combined into Fig. 2 (c), where each subgraph-subsequence pair has
two parent nodes, and hence this is no longer a tree. In this case, theoretically, we can compute
the support of each subgraph-subsequence pair in a dynamic-programming manner.
Proposition 2 (Dynamic programming for subgraph-subsequence pairs). Q(g,s) can be iteratively
computed as follows:
1. Q(g,s) = Q(parent(g),s) ∩Q(g,parent(s)).
2. Q(g,?s) = {(G,S) ∈ Q | g ∈ G}.
3. Q(?g ,s) = {(G,S) ∈ Q | s ∈ S}.
In practice, all combinations of frequent subgraphs and frequent subsequences may have a lot
of infrequent subgraph-subsequence pairs, and so we can use the downward closure property on
the product graph of the two enumeration trees, which can be clearly stated as follows:
Proposition 3 (Two-way downward closure for subgraph-subsequence pairs). If a subgraph-
subsequence pair (g, s) is infrequent, then subgraph-subsequence pairs (g′, s′) (where g ⊆ g′ and
s ⊆ s′) are all infrequent. Thus if support((g, s)|Q) = |Q(g,s)| < σ, then there is no need to extend
(g, s) further.
For example, if (C-C,L) (at node bB) in Fig. 2 (c) is infrequent, patterns at nodes (C-C-C,L),
(C-C=O,L), (C-C,LI), (C-C,LW), (C-C-C,LI), (C-C-C,LW), (C-C=O,LI) and (C-C=O,LW) must
be all infrequent.
The recursion rules in Proposition 2 make us keep all instances explicitly in the graph product
Tg × Ts. That is, Q(g,s) must be kept and be passed to subsequent nodes. This is a space-
consuming procedure, because two enumeration trees are practically very huge. Thus we can
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consider a depth-ﬁrst traversal of the graph product Tg × Ts by simplifying recursion rules in
Proposition 2 into those in the following Proposition 4 (See Note 6).
Proposition 4 (A simpliﬁed recursion rule). The recursion rules in Proposition 2 can be simplified
to
Q(g,s) = Q(parent(g),s) ∩ {(G,S) ∈ Q | g ∈ G} and Q(?g ,s) = {(G,S) ∈ Q | s ∈ S}.
We can obtain Q(g,s) eﬃciently by using Proposition 4 as follows: we can ﬁrst traverse Ts
until subsequence s is found, with computing marginal support, support((∗, s)|Q) (See Note 7).
We can then have Q(?g,s). We can further traverse Tg from node (∅g, s), keeping Q(·,s). Note
here that in this traversal, we can reduce the size of Q(·,s) by using the ﬁrst rule: Q(x,s) =
Q(parent(x),s)∩Q(x,?s), each time when parent(x) is extended to x. In this way, we can trace Q(g,s)
along with the path from Q(g,?s) to Q(g,s). This procedure can be applied to subgraph g, since
g and s are symmetric. In addition a larger enumeration tree should be examined ﬁrst for this
procedure, and in reality, we can examine Ts ﬁrst, since practically Ts is expected to be larger
than Tg in drug-target pairs. Finally we can present a pseudocode of the in silico mining method
as follows:
Proposition 5 (Pseudocode for enumerating all frequent subgraph-subsequence pairs).
1. Compute Q(g,?s) for all possible g using a frequent subgraph mining algorithm in terms of
support((g, ∗)|Q).
2. Start a frequent subsequence mining algorithm from (∅g,∅s):
For each s ∈ Ts in a depth-first traversal order:
For each g ∈ Tg in a depth-first traversal order:
- continue if g = ∅g or s = ∅s.
- reduce the size of Q(g,s) by Q(g,s) = Q(parent(g),s) ∩ Q(g,?s).
- compute support((g, s)|Q) = |Q(g,s)|.
- break if support((g, s)|Q) < σ.
We can explain this algorithm more by using a toy sample shown in Fig. 3, which has 10
graph-sequence pairs numbered as 1, 2, · · · , 10. Each cell of Fig. 3 shows graph-sequence pairs
having the corresponding subgraph-subsequence pair, such as that only graph-sequence pairs 4
and 5 have (C-C, L). Edges of the two enumeration trees in Fig. 2 are also shown by curves at
the outside of both rows and columns. The objective here is to ﬁnd all frequent pairs colored in
white: (C-O,L), (C-O,V), (C-O-C,L), (C-O-O,L), and (C-O-O,V).
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1 2 3 4 5 6 
7 8 9 10
1 2 3 4 5 4 5 6 7 8 9 1 2 3 3 4 5 4 5 6 6 7 8 9
4 5 6 7 
8 10
4 5 4 5 6 7 8 none 4 5 4 5 6 6 7 8
7 8 9 10 none 7 8 9 none none none 7 8 9
4 5 10 4 5 4 5 none 4 5 4 5 none
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Figure 3: A sample for enumerating all subgraph-subsequence pairs with the support of 3 or larger
under 10 graph-sequence pairs (1, 2, . . . , 10). This table corresponds to two enumeration trees of
Fig. 2 (a) and (b).
We ﬁrst build enumeration tree Tg, which corresponds to generating all subgraphs in the top
row of Fig. 3, and then starts traversing enumeration tree Ts from the root. By traversing Ts
in a depth-ﬁrst manner, the ﬁrst pattern to be found is (C-C,L). Since (C-C,L) is infrequent
(i.e. |Q(C-C,L)| < 3), we do not have to proceed to subsequent (C-C-C,L) and (C-C=O,L).
Then, the next subgraph-subsequence pair is (C-O,L), which turns out to be frequent. We then
move on to (C-O-C,L). Q(C-O-C,L) is obtained by Q(C-O-C,L) = Q(C-O,L) ∩ Q(C-O-C,?s) = {4, 5, 6}.
Similarly, we can move to (C-O-O,L) where Q(C-O-O,L) = Q(C-O,L) ∩ Q(C-O-C,?s) = {6, 7, 8}. We
now ﬁnished traversing all nodes of Tg for L ∈ Ts, and then we proceed to the next subgraph-
subsequence pair (C-C,LI) by traversing Ts from L to LI. However, subsequent nodes, (C-C,LI), (C-
O,LI), (C-C,LW), (C-O,LW) and (C-C,V) are all infrequent, and then the next frequent subgraph-
subsequence pair becomes (C-O,V). Then subsequent (C-O-C,V) and (C-O-O,V) are examined
in this order, and we can ﬁnd that (C-O-C,V) is infrequent but (C-O-O,V) is frequent. Then we
have no nodes to proceed in Tg × Ts, and the procedure is terminated. Finally we obtain all ﬁve
frequent patterns (C-O,L), (C-O-C,L), (C-O-O,L), (C-O,V) and (C-O-O,V) in this order.
3.2 Evaluating significance of subgraph-subsequence pairs
This statistical test is the same as that for detecting ‘epistasis’ in genetics [11], called likelihood
ratio test with logistic regression. We ﬁrst explain this test, focusing on drug-target pairs, being
followed by the method for maximizing the likelihood of logistic regression from given drug-target
pairs.
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3.2.1 Likelihood ratio test with logistic regression
Logistic regression can be deﬁned as the probability p that an event occurs given d explanatory
variables x1, x2, . . . , xd, as follows:
p = Prob{the event occurs | x1, x2, . . . , xd} = exp(η)1 + exp(η) =
1
1 + exp(−η) ,
where η = θ0+θ1x1+ · · ·+θdxd is a (linear) composite variable. Note that p takes a value between
zero and one due to the logistic function, even though η ranges from −∞ to ∞. Note further
that this equation can be transformed into log{ p1−p} = η where p1−p = Prob{the event occurs |
x1, x2, . . . , xd}/Prob{the event does not occur | x1, x2, . . . , xd}.
Let Y ∈ {0, 1} be a binary response variable, where the probability of Y = 0 (and Y = 1) is
modeled by




where θ = (θ0, θ1, . . . , θd)′ and Z = (1,X ′)′ = (1,X1,X2, . . . ,Xd)′. To ﬁt this model to n given
drug-target pairs for Y and X, {(y(1),x(1)), (y(2),x(2)), . . . , (y(n),x(n))} suﬃces to maximize the






(1− p„(x(i)))1−y(i) . (1)
For subgraph-subsequence pair (g, s), we can consider two explanatory variables X1 and X2
for subgraph g and subsequence s, respectively, each taking 1 if a graph-target pair has the
corresponding substructure; otherwise zero. We use two logistic regression models for Y where






1 + exp(η + θ3X1X2)
,
where η = θ0 + θ1X1 + θ2X2. Note that the second model has interaction term θ3X1X2 while the
ﬁrst model has no interaction terms. Parameters of these two models are independently ﬁtted by
maximizing the likelihood. Then, the signiﬁcance of pair (g, s) can be statistically measured by
testing whether θ3 = 0 is kept or not. Note that this can be conducted by using the likelihood
ratio test of two maximum likelihoods L̂θ:0-2 for pθ:0-2(X1,X2) and L̂θ:0-3 for pθ:0-3(X1,X2). The
test statistic −2 log(L̂θ:0-2/L̂θ:0-3) follows the chi-squared distribution with one degree of freedom
under the hypothesis that θ3 = 0. Thus, we can compute the p-value of the observed statistic
from the chi-squared distribution.
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3.2.2 Computing likelihood ratio test numerically
Given drug-target pairs, to maximize the likelihood (or ﬁt the logistic regression model to given
pairs), we can use the Newton-Raphson method, which is a typical and standard manner for
parameter estimation of logistic regression. Explanatory variables X1 and X2, as well as response
variable Y , are all binary (Y ∈ {0, 1},X1 ∈ {0, 1} and X2 ∈ {0, 1}), and thus drug-target pairs for
(Y,X1,X2) have eight possible combinations only, as shown in Table 1 (a). Thus, only what we
have to do is to count how many times each of the eight combinations occurs in given drug-target
pairs.
Table 1: Tables for counting eight values.
(a) model without the interaction term (b) model with the interaction term
explanatory response
X1 X2 #{Y = 1} #{Y = 0}
x00 0 0 P00 N00
x01 0 1 P01 N01
x10 1 0 P10 N10
x11 1 1 P11 N11
explanatory response
X1 X2 X1X2 #{Y = 1} #{Y = 0}
x000 0 0 0 P00 N00
x010 0 1 0 P01 N01
x100 1 0 0 P10 N10
x111 1 1 1 P11 N11
In fact, we can compute the likelihood ratio test using logistic regression from the counts of
eight possible combinations: P00, P01, P10, P11, N00, N01, N10, and N11 in Table 1. Denoting
(X1 = 0,X2 = 0) by x00, the probability that x00 is observed P00 times (from observations with
Y = 1) and N00 times (from observations with Y = 0) can be written:
P00︷ ︸︸ ︷
p(x00)× · · · × p(x00)×
N00︷ ︸︸ ︷
(1− p(x00))× · · · × (1− p(x00)) = p(x00)P00(1− p(x00))N00 ,
and the entire likelihood (θ) of Eq. (1) is implicitly given for binary variables Y , X1, and X2 by
p(x00)P00(1−p(x00))N00p(x01)P01(1−p(x01))N01p(x00)P10(1−p(x00))N10p(x11)P11(1−p(x00))N11 .
Thus, letting an index set be Λ := {00, 01, 10, 11}, the log-likelihood can be written as follows:



















which means that we can compute the p-value of likelihood ratio test using logistic regression
by using only P00, P01, P10, P11, N00, N01, N01, N11. To maximize L(θ) by changing θ, the
Newton-Raphson method repeats the following update:
θ[k+1] ← θ[k] + (∇2L(θ))−1∇L(θ) until
∣∣∣∣∣L(θ[k+1])− L(θ[k])L(θ[k])
∣∣∣∣∣ < ,






⎡⎣ ∑λ∈Λ(Pλ − (Pλ + Nλ)p(xλ))∑
λ∈Λ(x1)λ(Pλ − (Pλ + Nλ)p(xλ))∑




























(Pλ + Nλ)(xi)λ(xj)λp(xλ)(1− p(xλ)).
Hence, the Newton-Raphson update can be written in a matrix form:
θ[k+1] ← θ[k] + (X ′WX)−1X ′(y − p), (2)







⎤⎥⎥⎦ , W :=
⎡⎢⎢⎣
d00 0 0 0
0 d01 0 0
0 0 d10 0
0 0 0 d11






⎤⎥⎥⎦ , p :=
⎡⎢⎢⎣
(P00 + N00) pθ:0-2(x00)
(P01 + N01) pθ:0-2(x01)
(P10 + N10) pθ:0-2(x10)
(P11 + N11) pθ:0-2(x11)
⎤⎥⎥⎦ ,
d00 = (P00 + N00) pθ:0-2(x00)(1− pθ:0-2(x00)), d01 = (P01 + N01) pθ:0-2(x01)(1− pθ:0-2(x01)),
d10 = (P10 + N10) pθ:0-2(x10)(1− pθ:0-2(x10)), d11 = (P11 + N11) pθ:0-2(x11)(1− pθ:0-2(x11)),
and when we use a logistic model pθ:0-3(·) for p(·),
X :=
⎡⎢⎢⎣
1 0 0 0
1 0 1 0
1 1 0 0
1 1 1 1
⎤⎥⎥⎦ , W :=
⎡⎢⎢⎣
d000 0 0 0
0 d010 0 0
0 0 d100 0
0 0 0 d111






⎤⎥⎥⎦ , p :=
⎡⎢⎢⎣
(P00 + N00) pθ:0-3(x000)
(P01 + N01) pθ:0-3(x010)
(P10 + N10) pθ:0-3(x100)
(P11 + N11) pθ:0-3(x111)
⎤⎥⎥⎦ ,
d000 = (P00 + N00) pθ:0-3(x000)(1− pθ:0-3(x000)), d010 = (P01 + N01) pθ:0-3(x010)(1 − pθ:0-3(x010)),
d100 = (P10 + N10) pθ:0-3(x100)(1− pθ:0-3(x100)), d111 = (P11 + N11) pθ:0-3(x111)(1 − pθ:0-3(x111)).
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The deviance of maximum likelihood θˆ can be deﬁned by
D := −2(L(θˆ)− L∗)
where L∗ is the log-likelihood by the so-called full model (or saturated model) where probabilities



























Finally the deviance thus can be written by













1) Unknown drug-target pairs may be in non-interacting pairs. However we think that they are
statistically negligible, since the number of non-interacting pairs is huge.
2) 2D structures of drugs were converted into hydrogen-suppressed molecular graphs, where
nodes were labeled with atom types except hydrogens and edges are labeled with bond
types.
3) Drug substructures and target substructures mean connected subgraphs and consecutive sub-
sequences, respectively.
4) The support of a subgraph-subsequence pair is monotonically decreasing with increasing the
size of the subgraph or the subsequence, meaning that a subgraph on a deeper level in an
enumeration tree has a smaller support.
5) In the literature of mining frequent subsequences (or subgraphs), there already exist estab-
lished algorithms, such as the PreﬁxSpan algorithm [12] for frequent subsequences and the
gSpan algorithm [13] for frequent subgraphs. Here the original PreﬁxSpan algorithm allows
any size of gaps in subsequences, but we restrict to only consecutive subsequences. This
is because input sequences are amino acid sequences, which are usually long and consist of
only twenty amino acids, meaning that if we allow any size of gaps, small subsequences are
likely to be frequent, by which mining subsequences in protein sequences will be infeasible.
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7) This depth-ﬁrst traversal, which is similar to the gSpan and PreﬁxSpan algorithms, gives a
practically eﬃcient algorithm.
8) We can use any algorithm for mining frequent subgraphs (subsequences) to compute the
marginal support in Q with the traversal over Tg (and Ts). As mentioned above, for this
purpose, we use gSpan and PreﬁxSpan for graphs and sequences, respectively.
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